Comparison of microvessel density with tumor associated macrophages in invasive breast carcinoma

Anticancer Research

Volumn 18, Issue 5 B, 1998, Pages 3767-3770

  Jonjic N ^a   Valkovic T ^a   Lucin K ^a   Iternicka Z ^a   Krstulja, M ^a   Mustac E ^a   Dobi Babic R ^a   Sasso, F ^b   Melato, M ^b  

^a UNIVERSITY OF RIJEKA   (Croatia)

^b UNIVERSITY OF TRIESTE   (Italy)

Author keywords

Angiogenesis; Breast carcinoma; Tumor associated macrophages

Indexed keywords

CD68 ANTIGEN; MONOCLONAL ANTIBODY;

ARTICLE; BREAST CARCINOMA; CANCER GRADING; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MITOSIS RATE; PRIORITY JOURNAL; STATISTICAL ANALYSIS; TUMOR ASSOCIATED LEUKOCYTE; TUMOR VASCULARIZATION; TUMOR VOLUME; VASCULAR ENDOTHELIUM;

BIOLOGICAL MARKERS; BREAST NEOPLASMS; FEMALE; HUMANS; LYMPHATIC METASTASIS; MACROPHAGES; MITOTIC INDEX; NEOPLASM INVASIVENESS; NEOVASCULARIZATION, PATHOLOGIC; PROGNOSIS;

EID: 0031646709     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Folkman J, Cotran RS: Relation of vascular proliferation to tumor growth. Int Rev Exp Pathol 16: 207, 1976.
2. Weidner N, Folkman J, Pozza F, Bevilacqua P, Allred EN, Moore DH, Meli S, Gasparini G: Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma. J Natl Cancer Inst 84: 1875-87, 1992.
3. Weidner N, Semple JP, Welch WR, Folkman J: Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. N Engl J Med 324: 1-8, 1991.
4. Horak ER, Leek R, Klenk N, LeJeune S, Smith K, Stuart N, Greenall M, Stepniewska K, Harris AL: Angiogensis, assessed by platelet/endothelial cell adhesion antibodies, as indicator of node metastases and survival in breast cancer. Lancet 340: 1120-1124, 1992.
5. Weidner N, Gasparini G: Determination of epidermal growth factor receptor provides additonal prognostic information to measuring tumor angiogenesis in breast carcinoma patients. Breast Cancer Res Treat 29: 97-107, 1994.
6. Fox SB, Leek RD, Smith K, Hollyer J, Greenall M, Harris AL: Tumor angiogenesis in node-negative breast carcinomas-relationship with epidermal growth factor receptor, estrogen receptor, and survival. Breast Cancer Res Tret 29: 109-116, 1994.
7. Toi M, Kashitani J, Tominaga T: Tumor angiogenesis is an independent prognostic indicator in primary breast carcinoma. Int J Cancer 55: 371-374, 1993.
8. Bevilacqua P, Barbareschi M, Vederio P, Boracchi P, Caffo O, Dalla Palma P, Meli S, Weidner N, Gasparini G: Prognostic value of intratumoral microvessel density, a measure of tumor angiogenesis, in node-negative breast carcinoma-results of multiparametric study. Breast Cancer Res Tret 36: 205-217, 1995.
9. Bosari S, Lee AKC, DeLellis RA, Wiley BD, Heatley GJ, Silverman ML: Microvessel quantitation and prognosis in invasive breast carcinoma. Hum Pathol 23: 755-761, 1992.
10. Obermair A, Czerwenka K, Kurz C, Kaider A, Sevelda P: Tumoral vascular density in breast tumors and their effect on recurrence-free survaival. Chirurg 65: 611-615, 1994
11. Mantovani A, Bottazzi B, Govoni D, Colotta F, Sozzoni S, Ruco L: Origin and function of tumor-associated macrophages. Immunology Today 13: 265-270, 1992.
12. Zeigler-Heitbrock HEL, Theil C, Haas JG, Moller A, Rieth A, Muller G: Tumor necrosis factor in human monocyte-mediated antitumor cytotoxicity. Nat Immun Cell Growth Regul 7: 280-286, 1988.
13. Mantovani A, Ming WJ, Balotta C, Abdeljalil B, Bottazzi B: Origin and regulation of tumor-associated macrophages: The role of tumor-derived chemotactic factor. Biochem Biophys Acta 865: 59-67, 1986.
14. Wu S, Boyer CM, Whitaker RS, Berchuch A, Weinberg JB, Bast RCJ: Tumor necrosis factor-alpha as an autocrine and paracrine growth factor for ovarian cancer: monokine induction of tumor cell proliferation ant tumor necrosis factor-alpha expression. Cancer Res 51: 1939-1944, 1993.
15. Lorenzet R, Peri G, Locati D, Allavena P, Colucci M, Semeraro N, Mantovani A, Donati MB: Generation of procoagulant activity by mononuclear phagocytes: a possible mechanism contributing to blood clotting activation within malignant tissues. Blood 62: 271-273, 1983.
16. Polverini PJ, Leibovich SJ: Induction of neovascularization in vivo and endothelial proliferation in vitro by tumor associated macrophages. Lab Invest 51: 635-642, 1984.
17. Mussoni L, Riganti M, Acero R, Erroi A, Conforti G, Mantovani A, Donanti MB: Macrophages associated with murine tumours express plasminogen activator activity. Int J Caner 41: 227-230, 1988.
18. Mostofa LK, Jones DB, Wright DH: Mechanism of the induction of angiogenesis by human neoplastic lymphoid tissue: studies on the chorioallantoic membrane ofthe chick embryo. J Pathol 132: 191, 1980.
19. Folkman J: Tumor angiogensis: therapeutic implications. N Engl J Med 285: 1182-1186, 1971.
20. Folkman J: What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 82: 4-6, 1990.
21. Liotta LA, Steeg PS, Stetler-Stevenson WG: Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell 64: 327-336, 1991.
22. Weinstat-Saslow D, Steeg PS: Angiogenesis and colonization in the tumor metastatic process: basic and applied advances. FASEB J 8: 401-407, 1994.
23. Gast G, Hermann T, Steurer M, Zmija J, Gunsilius E, Unger C, Kraft: Angiogenesis as a target for tumor treatment. Oncology 54: 177-184, 1997.
24. Hildenbrand R, Dilger I, Horlin A et al: Urokinase Plasminogen Activator induces angiogenesis and tumor vessel inavsion in breast cancer. Pathol Res Pract 191: 403-409, 1995.
25. Goulding H, Nik Abdul Rashid NF, Robertson JF, Bell JA, Elston CW, Blarney RW, Ellis IO: Assessment of angiogensis in breast carcionam: An important factor in prognosis? Hum Pathol 26: 1196-1200, 1995.
26. Costello P, McCann A, Carney DN, Dervan PA: Prognostic significance of microvessel density in lymph node negative breast carcinoma. Hum Pathol 26: 1181-1184, 1995.
27. Siitonen SM, Haapasalo HK, Rantala IS, Helin HJ, Isola JJ: Comparison of different immunohistochemical methods in the assessment of angiogensis: lack of prognostic value in a group of 77 selected node-negative breast carcinomas. Mod Pathol 8: 745-52, 1995.
28. Van Netten JP, Ashmead BJ, Parker RL, Thornton IG, Fletcher C, Cavers D, Coy P, Brigden ML: Macrophage-tumor cell association: a factor in metastasis of breast cancer? J Leukoc Biol 54: 360-362, 1993.
29. Norman SJ: Macrophage infiltration and tumor progression. Cancer Metastasis Rev 4: 327-336, 1985.
30. Wu S, Boyer CM, Whitaker RS, Berchuch A, Wiener JR, Weinberg JB, Bast RCJ: Tumor necrosis factor alpha as an autocrine and paracrine growth factor for ovarian cancer: monokine induction of tumar cell proliferation and tumor necrosis factor alpha expression. Cancer Res 53: 1939-1944, 1993.
31. O'Sullivan C, Lewis CE, Harris AL, McGee JOD : Secretion of epidermal growth factor by macrophages associated with breast carcinoma. Lancet 342: 148-149, 1993.
32. Van Netten JP, Ashmead BJ, Cevers D, Fletcher C, Thornton IG, Antonson BL, Coy P, Brigden ML: Macrophages and their putative significance in human breast cancer. Br J Cancer 66: 220-221, 1992.
33. Pupa SM, Bufalino R, Inverizzi AM, Andreola S, Rilke F, Lombardi L, Colnaghi MI, Menard S Macrophage infiltrate and prognosis in c-erbB-2 overexpression breast carcinoma. J Clin Oncol 14: 85-94, 1996.
34. Zuk JA, Walker RA: Immunohistochemical analysis of HLA antigens and mononuclear infiltrates of benign and malignant breast. J Pathol 152: 275-285, 1987.
35. Leek RD, Lewis CE, Witehous R, Greenall M, Clarke J, Harris AL: Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma. Cancer Res 56: 4625-4629, 1996.